Literature DB >> 1962456

A vaccinia virus isatin-beta-thiosemicarbazone resistance mutation maps in the viral gene encoding the 132-kDa subunit of RNA polymerase.

R C Condit1, R Easterly, R F Pacha, Z Fathi, R J Meis.   

Abstract

The mutation in a vaccinia virus mutant resistant to inhibition by isatin-beta-thiosemicarbazone was mapped by marker rescue. DNA from the resistant mutant was cloned into cosmid and plasmid vectors and tested for its ability to convert wild-type vaccinia virus to IBT resistant virus in a helper-mediated marker rescue protocol. Resistance was mapped in this way to a 0.9-kb DNA fragment derived from the HindIII A fragment of vaccinia genome. Southern blot hybridization using this DNA as a probe demonstrated that the 0.9-kb fragment is contained within the DNA sequence encoding the second largest subunit of vaccinia RNA polymerase, rpo132. Thus, mutation of rpo132 can cause resistance to IBT in vaccinia virus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1962456     DOI: 10.1016/0042-6822(91)90559-t

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice.

Authors:  Graciela Andrei; Don B Gammon; Pierre Fiten; Erik De Clercq; Ghislain Opdenakker; Robert Snoeck; David H Evans
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor.

Authors:  Y Xiang; D A Simpson; J Spiegel; A Zhou; R H Silverman; R C Condit
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

3.  Emergence of a Viral RNA Polymerase Variant during Gene Copy Number Amplification Promotes Rapid Evolution of Vaccinia Virus.

Authors:  Kelsey R Cone; Zev N Kronenberg; Mark Yandell; Nels C Elde
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

4.  Genetic Confirmation that the H5 Protein Is Required for Vaccinia Virus DNA Replication.

Authors:  Kathleen A Boyle; Matthew D Greseth; Paula Traktman
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

5.  A targeted approach to identification of vaccinia virus postreplicative transcription elongation factors: genetic evidence for a role of the H5R gene in vaccinia transcription.

Authors:  Steven G Cresawn; Richard C Condit
Journal:  Virology       Date:  2007-03-21       Impact factor: 3.616

Review 6.  Orthopoxvirus targets for the development of antiviral therapies.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Curr Drug Targets Infect Disord       Date:  2005-03

7.  Phenotypic characterization of mutants in vaccinia virus gene G2R, a putative transcription elongation factor.

Authors:  E P Black; R C Condit
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  Genetic characterization of the vaccinia virus DNA polymerase: cytosine arabinoside resistance requires a variable lesion conferring phosphonoacetate resistance in conjunction with an invariant mutation localized to the 3'-5' exonuclease domain.

Authors:  J A Taddie; P Traktman
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Barrier to autointegration factor (BAF) inhibits vaccinia virus intermediate transcription in the absence of the viral B1 kinase.

Authors:  Nouhou Ibrahim; April Wicklund; Augusta Jamin; Matthew S Wiebe
Journal:  Virology       Date:  2013-07-24       Impact factor: 3.616

10.  The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF.

Authors:  Amber B Rico; Alexandria C Linville; Annabel T Olson; Zhigang Wang; Matthew S Wiebe
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.